{
    "Trade/Device Name(s)": [
        "Oratect\u00ae Oral Fluid Drug Screen Device",
        "OratectCheck\u2122 Oral Fluid Controls"
    ],
    "Submitter Information": "Branan Medical Corp.",
    "510(k) Number": "K103227",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992918",
        "K001197",
        "K002375",
        "K981341",
        "K000399"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "DJC",
        "DIO",
        "DJG",
        "LCM",
        "LDJ",
        "DIF"
    ],
    "Summary Letter Date": "April 09, 2012",
    "Summary Letter Received Date": "April 10, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100",
        "21CFR862.3870",
        "21CFR863.3250",
        "21CFR862.3610",
        "21CFR862.3650",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Cannabinoids test system",
        "Cocaine and cocaine metabolite test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-Amphetamine",
        "d-Methamphetamine",
        "Delta-9-Tetrahydrocannabinol (THC)",
        "Cocaine",
        "Morphine",
        "Phencyclidine (PCP)"
    ],
    "Specimen Type(s)": [
        "Oral fluid (human saliva)"
    ],
    "Specimen Container(s)": [
        "Oratect\u00ae Oral Fluid Collection Tube (50 mL polypropylene tube)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Immunoassay"
    ],
    "Methodologies": [
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Control",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Oratect Oral Fluid Drug Screen Device and OratectCheck Oral Fluid Controls for qualitative detection of drugs in oral fluid using lateral flow immunoassay.",
    "Indications for Use Summary": "Preliminary drug screening test for qualitative detection of d-Methamphetamine, Delta-9-Tetrahydrocannabinol, Cocaine, d-Amphetamine, Morphine, and Phencyclidine in human oral fluid at specified cutoff concentrations; for in vitro prescription point-of-care use.",
    "fda_folder": "Toxicology"
}